Intravenously administered propidium iodide labels necrotic cells in the intact mouse brain after injury.
Unal Cevik
I
I
Dalkara
T
T
D000818:Animals; D017209:Apoptosis; D015415:Biomarkers; D006690:Bisbenzimidazole; D001921:Brain / Q000378:metabolism / Q000473:pathology; D001930:Brain Injuries / Q000473:pathology*; D016923:Cell Death; D020925:Hypoxia-Ischemia, Brain / Q000175:diagnosis / Q000378:metabolism / Q000473:pathology; D020287:In Situ Nick-End Labeling; D020244:Infarction, Middle Cerebral Artery / Q000378:metabolism / Q000473:pathology; D007275:Injections, Intravenous; D007276:Injections, Intraventricular; D051379:Mice; D008856:Microscopy, Fluorescence; D009336:Necrosis; D011419:Propidium / Q000008:administration & dosage* / Q000493:pharmacokinetics; D011933:Reagent Kits, Diagnostic
D015415:Biomarkers; D011933:Reagent Kits, Diagnostic; D011419:Propidium; D006690:Bisbenzimidazole